Lv4
730 积分 2024-08-06 加入
Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
3天前
已完结
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
8天前
已完结
Population pharmacokinetics of mycophenolic acid in paediatric patients
8天前
已完结
Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid and Their Relation to Response to Therapy of Childhood-Onset Systemic Lupus Erythematosus
21天前
已完结
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
21天前
已完结
Mycophenolate mofetil for lupus nephritis: an update
21天前
已完结
Population pharmacokinetic and dose optimization of mycophenolic acid in children with anti-neutrophilic cytoplasmic antibody-associated nephritis
1个月前
已完结
Mycophenolate Mofetil: How to Further Improve Using an Already Successful Drug?
1个月前
已完结
Determination of mycophenolic acid in human plasma by ultra‐performance liquid chromatography–tandem mass spectrometry and its pharmacokinetic application in kidney transplant patients
1个月前
已完结
Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study
1个月前
已完结
皖公网安备34019202002308
